What Hims & Hers' Labs AI Launch Means for Concierge Medicine in 2026
On May 7, 2026, Hims Hers (NYSE: HIMS) launched Labs AI , an embedded artificial intelligence agent that reads a customer's bloodwork and explains it in plain language. The product covers 130 biomarker tests across 10 health categories, including heart health, metabolism, hormones, inflammation, and stress.
May 20, 2026










